Table 3—

Treatment of acute viral bronchiolitis

MedicineQuality of evidenceRecommendation
BronchodilatorsBronchodilators have no effect on the course of acute bronchiolitis (high)Epinephrine may have a modest effect among outpatients (moderate)Bronchodilators should not be used routinelyIndividual trial of bronchodilators may be justified, but discontinued if no benefit is seen
Inhaled steroidsInhaled corticosteroids have no effect either on the course of acute bronchiolitis (high) or on post-bronchiolitic cough and wheeze (moderate)Inhaled corticosteroids should not be used
Systemic corticosteroidsSystemic corticosteroids have no or minimal effect on the course of acute bronchiolitis (high)Systemic corticosteroids should not be used
Leukotriene receptor antagonistsMontelukast does not have a beneficial effect on the course of acute bronchiolitis (moderate) or on the recurrence of wheeze following acute bronchiolitis (moderate)Montelukast should not be used
ImmunoglobulinsImmunoglobulins have no effect on the course of acute bronchiolitis (high)Immunoglobulins should not be used
Monoclonal antibodiesRSV-specific monoclonal antibodies do not alter the course of acute RSV bronchiolitis after onset of symptoms (moderate)RSV monoclonal antibodies should not be used to treat acute viral bronchiolitis (they are used for prevention in high-risk infants)
AntibioticsAntibiotics have no effect on the course of acute bronchiolitis (high)Antibiotics should not be used
Antiviral treatmentThere is little evidence of a positive effect of ribavirin on the course of acute bronchiolitis (moderate)Ribavirin should not be used
Chest physiotherapyChest physiotherapy has no positive effect on the course of acute bronchiolitis (moderate)Physiotherapy should not be used
Hypertonic salineHypertonic saline has a beneficial effect on the course of acute bronchiolitis (moderate)Hypertonic saline should probably be used
  • RSV: respiratory syncytial virus.